Travere Therapeutics Inc (TVTX)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 53.5M | 55.87M | 56.99M | 59.7M | -16.51M | 45.06M | 41.37M | 54.12M |
営業利益 | -68.13M | -66.85M | -87.05M | -87.58M | -127.87M | -94.23M | -139.24M | -67.7M |
税引前収入 | -69.51M | -65.76M | -86.25M | -85.57M | -115.76M | -88.53M | -135.77M | -69.57M |
純利益 | -69.66M | -65.82M | -86.33M | -85.63M | 150.74M | -90.17M | -136.06M | -70.41M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -68.72M | -67.28M | -86.96M | -87.7M | -127.65M | -93.36M | -139M | -70.96M |
EBITDA | -59.56M | -57.55M | -77.5M | -73.68M | -122.28M | -84.79M | -120.01M | -66.71M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 133.59M | 154.94M | 164.49M | 193.34M | 198.32M | 227.49M | 212.02M | 145.24M |
営業利益 | -58.36M | -53.79M | -80.04M | -122.36M | -176.16M | -161.77M | -266.57M | -388.14M |
税引前収入 | -57.72M | -58.36M | -101.87M | -146.45M | -188.79M | -179.68M | -278.17M | -376.11M |
純利益 | -48.05M | -59.73M | -102.68M | -146.43M | -169.43M | -180.09M | -278.48M | -111.4M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -1.267 | -1.517 | -2.481 | -3.398 | -3.243 | -2.882 | -4.332 | -1.482 |
EBIT | -58.62M | -52.68M | -97.56M | -122.68M | -174.74M | -161.53M | -266.99M | -387.04M |
EBITDA | -42.22M | -35.99M | -61.37M | -76.45M | -151.58M | -135.15M | -233.49M | -349.66M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約